{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T02:04:27Z","timestamp":1649210667433},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Charcot foot is a severe complication to diabetes mellitus, associated with diabetic neuropathy. Any long-term effects of a Charcot foot on the progress of neuropathy are still largely unexplored. The objective was to investigate whether a previous Charcot foot had any long-term effects on the progress of neuropathy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>An 8.5-year follow-up case\u2013control study of 49 individuals with diabetes mellitus, 24 of whom also had Charcot foot at baseline visit in 2005\u20132007. Neuropathy was assessed with a questionnaire, biothesiometry, heart rate variability and venous occlusion plethysmography. Of the 49 baseline participants, 22 were able to participate in the follow-up. Twelve had passed away in the meantime. Heart rate variability was unchanged in both groups; from 9.7 to 7.2\u00a0beats\/min (p\u00a0=\u00a00.053) in the Charcot group, and 14.3 to 12.6\u00a0beats\/min (p\u00a0=\u00a00.762) in the control group. Somato-sensoric neuropathy showed no difference between baseline and follow-up in the Charcot group (from 39.1 to 38.5\u00a0V) (p\u00a0=\u00a00.946), but a significantly worsened sensitivity in the control group (from 25.1 to 38.9\u00a0V) (p\u00a0=\u00a00.002). In conclusion, we found that any differences in somatic or cardial autonomic neuropathy present at baseline had disappeared at follow-up after 8.5\u00a0years.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13104-018-3253-5","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T03:35:36Z","timestamp":1519097736000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term effects on the progress of neuropathy after diabetic Charcot foot: an 8.5-year prospective case\u2013control study"],"prefix":"10.1186","volume":"11","author":[{"given":"Rasmus Bo","family":"Jansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"M\u00f8ller Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"B\u00fclow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene","family":"R\u00f8rdam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per E.","family":"Holstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole Lander","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"issue":"5","key":"3253_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10016-003-0039-5","volume":"17","author":"L Lee","year":"2003","unstructured":"Lee L, Blume PA, Sumpio B. Charcot joint disease in diabetes mellitus. Ann Vasc Surg. 2003;17(5):571\u201380.","journal-title":"Ann Vasc Surg"},{"issue":"5","key":"3253_CR2","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.mcna.2013.04.003","volume":"97","author":"LC Rogers","year":"2013","unstructured":"Rogers LC, Frykberg RG. The charcot foot. Med Clin North Am. 2013;97(5):847\u201356.","journal-title":"Med Clin North Am"},{"issue":"Suppl 1","key":"3253_CR3","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1002\/dmrr.846","volume":"24","author":"NL Petrova","year":"2008","unstructured":"Petrova NL, Edmonds ME. Charcot neuro-osteoarthropathy-current standards. Diabetes Metab Res Rev. 2008;24(Suppl 1):S58\u201361.","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"3253_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF00283741","volume":"22","author":"JD Ward","year":"1982","unstructured":"Ward JD. The diabetic leg. Diabetologia. 1982;22(3):141\u20137.","journal-title":"Diabetologia"},{"issue":"5","key":"3253_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.7547\/1010437","volume":"101","author":"LC Rogers","year":"2011","unstructured":"Rogers LC, Frykberg RG, Armstrong DG, Boulton AJM, Edmonds M, Van GH, et al. The Charcot foot in diabetes. J Am Podiatr Med Assoc. 2011;101(5):437\u201346.","journal-title":"J Am Podiatr Med Assoc"},{"issue":"9347","key":"3253_CR6","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/S0140-6736(02)11671-0","volume":"360","author":"A Hartemann-Heurtier","year":"2002","unstructured":"Hartemann-Heurtier A, Van GH, Grimaldi A. The Charcot foot. Lancet. 2002;360(9347):1776\u20139.","journal-title":"Lancet"},{"issue":"6","key":"3253_CR7","doi-asserted-by":"publisher","first-page":"796","DOI":"10.2337\/diacare.23.6.796","volume":"23","author":"J Fabrin","year":"2000","unstructured":"Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care. 2000;23(6):796\u2013800.","journal-title":"Diabetes Care"},{"issue":"5","key":"3253_CR8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jdiacomp.2011.06.006","volume":"25","author":"TM Christensen","year":"2011","unstructured":"Christensen TM, Simonsen L, Holstein PE, Svendsen OL, B\u00fclow J. Sympathetic neuropathy in diabetes mellitus patients does not elicit Charcot osteoarthropathy. J Diabetes Complic. 2011;25(5):320\u20134.","journal-title":"J Diabetes Complic"},{"issue":"9502","key":"3253_CR9","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1016\/S0140-6736(05)67029-8","volume":"366","author":"WJ Jeffcoate","year":"2005","unstructured":"Jeffcoate WJ, Game F, Cavanagh PR. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet. 2005;366(9502):2058\u201361.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"3253_CR10","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1002\/dmrr.837","volume":"24","author":"WJ Jeffcoate","year":"2008","unstructured":"Jeffcoate WJ. Charcot neuro-osteoarthropathy. Diabetes Metab Res Rev. 2008;24(Suppl 1):S62\u20135.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"3253_CR11","first-page":"84","volume":"10","author":"G Mabilleau","year":"2010","unstructured":"Mabilleau G, Edmonds ME. Role of neuropathy on fracture healing in Charcot neuro-osteoarthropathy. J Musculoskelet Neuronal Interact. 2010;10(1):84\u201391.","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"6","key":"3253_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1055\/s-2006-944525","volume":"38","author":"E Chantelau","year":"2006","unstructured":"Chantelau E, Onvlee GJ. Charcot foot in diabetes: farewell to the neurotrophic theory. Horm Metab Res Horm Stoffwechselforschung Horm M\u00e9tabolisme. 2006;38(6):361\u20137.","journal-title":"Horm Metab Res Horm Stoffwechselforschung Horm M\u00e9tabolisme"},{"issue":"5","key":"3253_CR13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jdiacomp.2012.05.006","volume":"26","author":"TM Christensen","year":"2012","unstructured":"Christensen TM, Gade-Rasmussen B, Pedersen LW, Hommel E, Holstein PE, Svendsen OL. Duration of off-loading and recurrence rate in Charcot osteo-arthropathy treated with less restrictive regimen with removable walker. J Diabetes Complic. 2012;26(5):430\u20134.","journal-title":"J Diabetes Complic"},{"issue":"3","key":"3253_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1177\/1071100712464957","volume":"34","author":"G Osterhoff","year":"2013","unstructured":"Osterhoff G, B\u00f6ni T, Berli M. Recurrence of acute Charcot neuropathic osteoarthropathy after conservative treatment. Foot Ankle Int. 2013;34(3):359\u201364.","journal-title":"Foot Ankle Int"},{"issue":"2","key":"3253_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1475-097X.2009.00915.x","volume":"30","author":"TM Christensen","year":"2010","unstructured":"Christensen TM, B\u00fclow J, Simonsen L, Holstein PE, Svendsen OL. Bone mineral density in diabetes mellitus patients with and without a Charcot foot. Clin Physiol Funct Imaging. 2010;30(2):130\u20134.","journal-title":"Clin Physiol Funct Imaging"},{"key":"3253_CR16","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jdiacomp.2015.05.020","volume":"29","author":"RB Jansen","year":"2015","unstructured":"Jansen RB, Christensen TM, B\u00fclow J, R\u00f8rdam L, Holstein PE, Svendsen OL. Sarcopenia and body composition in diabetic Charcot osteoarthropathy. J Diabetes Complic. 2015;29:937\u201342.","journal-title":"J Diabetes Complic"},{"issue":"6","key":"3253_CR17","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/ana.410080608","volume":"8","author":"PJ Dyck","year":"1980","unstructured":"Dyck PJ, Sherman WR, Hallcher LM, Service FJ, O\u2019Brien PC, Grina LA, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol. 1980;8(6):590\u20136.","journal-title":"Ann Neurol"},{"issue":"1","key":"3253_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/mus.880110106","volume":"11","author":"PJ Dyck","year":"1988","unstructured":"Dyck PJ. Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve. 1988;11(1):21\u201332.","journal-title":"Muscle Nerve"},{"issue":"6","key":"3253_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2337\/diacare.17.6.557","volume":"17","author":"MJ Young","year":"1994","unstructured":"Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care. 1994;17(6):557\u201360.","journal-title":"Diabetes Care"},{"issue":"3","key":"3253_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/archinte.158.3.289","volume":"158","author":"DG Armstrong","year":"1998","unstructured":"Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med. 1998;158(3):289\u201392.","journal-title":"Arch Intern Med"},{"issue":"6","key":"3253_CR21","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2337\/diacare.23.6.750","volume":"23","author":"JW Meijer","year":"2000","unstructured":"Meijer JW, van Sonderen E, Blaauwwiekel EE, Smit AJ, Groothoff JW, Eisma WH, et al. Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care. 2000;23(6):750\u20133.","journal-title":"Diabetes Care"},{"issue":"6106","key":"3253_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/bmj.1.6106.145","volume":"1","author":"DJ Ewing","year":"1978","unstructured":"Ewing DJ, Campbell IW, Murray A, Neilson JM, Clarke BF. Immediate heart-rate response to standing: simple test for autonomic neuropathy in diabetes. Br Med J. 1978;1(6106):145\u20137.","journal-title":"Br Med J"},{"issue":"1","key":"3253_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1113\/jphysiol.1953.sp004926","volume":"121","author":"RJ Whitney","year":"1953","unstructured":"Whitney RJ. The measurement of volume changes in human limbs. J Physiol. 1953;121(1):1\u201327.","journal-title":"J Physiol"},{"issue":"1","key":"3253_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1046\/j.1365-2281.1998.00073.x","volume":"18","author":"H Zachrisson","year":"1998","unstructured":"Zachrisson H, Volkmann R, Bergerheim T, Holm J. Selectivity of superficial vein occlusion at the ankle and calf level: a methodological study in healthy volunteers. Clin Physiol Oxf Engl. 1998;18(1):55\u201360.","journal-title":"Clin Physiol Oxf Engl"},{"issue":"5","key":"3253_CR25","doi-asserted-by":"publisher","first-page":"816","DOI":"10.2337\/dc08-1695","volume":"32","author":"M-W Sohn","year":"2009","unstructured":"Sohn M-W, Lee TA, Stuck RM, Frykberg RG, Budiman-Mak E. Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone. Diabetes Care. 2009;32(5):816\u201321.","journal-title":"Diabetes Care"},{"issue":"2","key":"3253_CR26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2337\/diacare.26.2.491","volume":"26","author":"PK Moulik","year":"2003","unstructured":"Moulik PK, Mtonga R, Gill GV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care. 2003;26(2):491\u20134.","journal-title":"Diabetes Care"},{"issue":"10","key":"3253_CR27","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.2337\/dc12-0200","volume":"35","author":"S Morbach","year":"2012","unstructured":"Morbach S, Furchert H, Gr\u00f6blinghoff U, Hoffmeier H, Kersten K, Klauke G-T, et al. Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care. 2012;35(10):2021\u20137.","journal-title":"Diabetes Care"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-018-3253-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-018-3253-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-018-3253-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T10:04:20Z","timestamp":1641377060000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-018-3253-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3253"],"URL":"https:\/\/doi.org\/10.1186\/s13104-018-3253-5","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,20]]},"assertion":[{"value":"19 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The given name of the author Ole Lander Svendsen has been updated from \u201cOle\u201d to \u201cOle Lander\u201d.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"140"}}